{
  "docId": "019dd923-622c-750b-8b9a-3bcd52c6e583",
  "docSlug": "f06b0b5d2079",
  "documentTitle": "Soleno Therapeutics (SLNO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-08-15 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 55,
  "pageCount": 415,
  "prevPage": 54,
  "nextPage": 56,
  "slideType": "villain_critique",
  "function": "name_villain",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "The slide uses a 'villain_critique' approach by leveraging an expert's authority to discredit the company's product.",
  "elementsJson": [
    "headline_text",
    "bullet_list",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-3bcd52c6e583/55",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583#slide-55",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "I didn't see $500,000 worth of – or $5,000 worth of benefit; I've been around a long time. I won't use it.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-64cd-733b-acae-a0f0c43062c9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.86,
        "x": 0.07,
        "y": 0.58
      },
      "kind": "list",
      "text": "Indicated the trials were just statistical artifacts with no observable difference in patients whether hyperphagia or weight; would advise other physicians to avoid using the drug: “I would say hold off...”; “I just didn’t think it worked...”; “they got a statistician who did all this remarkable testing and, oh, we came up with something...I think they played with the data until they finally got something that worked.”",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1f1af532-8890-4134-9f6c-f6fcbc7671d0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.86,
        "x": 0.07,
        "y": 0.75
      },
      "kind": "list",
      "text": "Indicated widespread skepticism in the field of Vykat by other trial investigators and PWS specialists who collectively manage a large percentage of the patients; expects it to be a dud within 3 to 6 months as failures and safety issues mount; “I don’t think anyone would say ‘Whoa, we got to get these patients on this drug...look what it can do...a lot of people are taking a hands-off, let’s just see...I haven’t heard from people with much enthusiasm”; “those who are the most experienced are probably not as excited about it than those that are newer...”",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1f914abc-6f34-405d-ba03-21f3494a3a9e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.86,
        "x": 0.07,
        "y": 0.45
      },
      "kind": "list",
      "text": "Stated that he’s working on a paper about cardiac risk from Vykat: “I have more than concern about it...in fact, I’m writing an article on it...I’ve been asked to write my opinion on this trial in the medical literature”; “yeah, lots of different issues...we still don’t have a clear understanding, even though the drug has been around since 1976.”",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "243d7160-310e-465f-bbd2-4a1ea2f95de0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.86,
        "x": 0.07,
        "y": 0.28
      },
      "kind": "list",
      "text": "Thinks that Vykat is a failure and has no effect on hyperphagia or weight; that it is dangerous and at risk of an existential Zafgen-type safety debacle; has no plans to put any patients on it; thinks that Soleno played games with the data; and that it should never have been approved by the FDA, which he believes was due to pressure from desperate families: “I didn’t see $500,000 worth of – or $5,000 worth of benefit”; “I’ve been around a long time. I won’t use it.”",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5d8c3746-7e94-41b6-bfea-dd105c36f34c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "I didn't see $500,000 worth of – or $5,000 worth of benefit; I've been around a long time. I won't use it. — Trial investigator #1",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-64cd-733b-acae-a43dfe4a703d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.25,
        "x": 0.07,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2c10dce5-e0ef-4a7c-9254-6f6e4b823cf3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.18,
        "w": 0.86,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "title",
      "text": "Trial investigator #1: One of the most prominent, published, and influential authorities in Prader Willi Syndrome; involved with a dozen clinical trials in the past; directly treats or monitors >100 PWS patients – one of the largest caseloads in the field; advises other PWS practitioners around the world. Long history with Soleno and played a key role in the Vykat trials; co-author on trial paper.",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "16a9a35e-e112-4ee9-8bc0-2ce8cd96082f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}